Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial

PURPOSE: Doxorubicin is a key component in many pediatric oncology treatment regimens; still pharmacology data on which current dosing regimens are based are very limited. METHODS: We conducted a multinational pharmacokinetic study investigating age dependency of doxorubicin metabolism and eliminati...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Chemother Pharmacol
Prif Awduron: Krischke, Miriam, Hempel, Georg, Völler, Swantje, André, Nicolas, D’Incalci, Maurizio, Bisogno, Gianni, Köpcke, Wolfgang, Borowski, Matthias, Herold, Ralf, Boddy, Alan V., Boos, Joachim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114325/
https://ncbi.nlm.nih.gov/pubmed/27770238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3174-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg